Implementing Digital pathology and AI in cancer diagnosis alleviates impact of pathologist shortage through improved workflow and remote collaboration capabilities ...
The latest milestone follows PathAI’s 510(k) clearance for AISight Dx, the first FDA-approved digital pathology system.
PathAI, Inc., a global leader in artificial intelligence (AI)-powered pathology solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation ...
Fujifilm’s AI-driven medical informatics solutions that will be highlighted at booth #1617 include: ...
Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...
Artificial intelligence has a critical role to play in supporting clinicians beyond the initial breast cancer diagnosis. At the European Society of Breast Imaging (EUSOBI) annual scientific meeting in ...
Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...
The software is designed to analyze digital pathology whole-slide images of skin lesions and aid pathologists in their review.
Neurodegenerative disorders such as Alzheimer's disease (AD) are typically diagnosed after irreversible pathology has developed. Aging, the strongest risk factor, drives molecular changes that ...
Deloitte and ServiceNow today reveal the five key trends defining the next era of automation in the 2026 Workflow Automation Outlook: From Insights to Impact - Connecting the AI-Fueled Enterprise in ...
Vivere Partners, a specialty insurance underwriting platform focused on niche lines of business, today announced a strategic relationship with Berkshire Hathaway Specialty Insurance (BHSI) to launch a ...
In little moments like when sipping coffee or licking an ice cream cone, it doesn't seem like your body is pulling off a ...